Evidence map›Paper›PMID 22628435›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2012

Angiopoietin-1 and vascular endothelial growth factor regulation of leukocyte adhesion to endothelial cells: role of nuclear receptor-77.

Hodan Ismail, Mahroo Mofarrahi, Raquel Echavarria, Sharon Harel, Eric Verdin, Hyung W Lim, Zheng-Gen Jin, Jianxin Sun, Huiyan Zeng, Sabah N A Hussain

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Nur77 limits endothelial barrier disruption to LPS in the mouse lung.American journal of physiology. Lung cellular and molecular physiology · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Antitumor activity of SAHA, a novel histone deacetylase inhibitor, against murine B cell lymphoma A20 cells in vitro and in vivo.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  20. NR4A nuclear receptors in immunity and atherosclerosis.Current opinion in lipidology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Hodan IsmailCritical Care and Respiratory Divisions, Department of Medicine, McGill University Health Centre and Meakins-Christie Laboratories, McGill University, Montréal, Québec, Canada.
Mahroo Mofarrahi
Raquel Echavarria
Sharon Harel
Eric Verdin
Hyung W Lim
Zheng-Gen Jin
Jianxin Sun
Huiyan Zeng
Sabah N A Hussain
University of California, San Francisco · USGladstone Institutes · USThomas Jefferson University · US

Funding

Regulation of Endothelial Nitric Oxide Synthase mRNA StabilityR01HL103869 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI SUN, JIANXIN · 2010 to 2020
$3.5M
Receptor Tyrosine Kinases in MechanotransductionR01HL080611 · NHLBI · UNIVERSITY OF ROCHESTER · PI JIN, ZHENG-GEN · 2005 to 2009
$2.1M
Molecular regulation of angiogenesisR01HL114570 · NHLBI · UNIVERSITY OF ROCHESTER · PI JIN, ZHENG-GEN · 2012 to 2016
$1.9M
CIHRNHLBI NIH HHS 5R01HL080611NHLBI NIH HHS 7R01HL103869NHLBI NIH HHS R01 HL080611NHLBI NIH HHS R01 HL103869NHLBI NIH HHS R01 HL114570
6 · The paper itself

Abstract

objectiveVascular endothelial growth factor (VEGF) promotes leukocyte adhesion to endothelial cells (ECs). Angiopoietin-1 (Ang-1) inhibits this response. Nuclear receptor-77 (Nur77) is a proangiogenic nuclear receptor. In the present study, we assessed the influence of Ang-1 and VEGF on Nur77 expression in ECs, and evaluated its role in Ang-1/VEGF-mediated leukocyte adhesion. METHODS AND

resultsExpression of Nur77 was evaluated with real-time polymerase chain reaction and immunoblotting. Adhesion of leukocytes to ECs was monitored with inverted microscopy. Nur77 expression or activity was inhibited using adenoviruses expressing dominant-negative form of Nur77, retroviruses expressing Nur77 in the antisense direction, and small interfering RNA oligos. Both Ang-1 and VEGF induce Nur77 expression, by >5- and 30-fold, respectively. When combined, Ang-1 potentiates VEGF-induced Nur77 expression. Ang-1 induces Nur77 through the phosphoinositide 3-kinase and extracellular signal-regulated protein kinase 1/2 pathways. VEGF induces Nur77 expression through the protein kinase D/histone deacetylase 7/myocyte enhancer factor 2 and extracellular signal-regulated protein kinase 1/2 pathways. VEGF induces nuclear factor-kappaB transcription factor, vascular cell adhesion molecule-1, and E-selectin expressions, and promotes leukocyte adhesion to ECs. Ang-1 inhibits these responses. This inhibitory effect of Ang-1 disappears when Nur77 expression is disrupted, restoring the inductive effects of VEGF on adhesion molecule expression, and increased leukocyte adhesion to ECs.

conclusionsNur77 promotes anti-inflammatory effects of Ang-1, and functions as a negative feedback inhibitor of VEGF-induced EC activation.

Indexed as

Angiopoietin-1Cell AdhesionCells, CulturedEndothelial CellsHistone DeacetylasesHumansI-kappa B KinaseLeukocytesNF-kappa BNuclear Receptor Subfamily 4, Group A, Member 1Phosphatidylinositol 3-KinasesPhosphorylationProto-Oncogene Proteins c-aktTRPP Cation ChannelsU937 CellsVascular Cell Adhesion Molecule-1Angiopoietin-1HDAC7 protein, humanHistone DeacetylasesI-kappa B KinaseNF-kappa BNR4A1 protein, humanNuclear Receptor Subfamily 4, Group A, Member 1Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTRPP Cation ChannelsVascular Cell Adhesion Molecule-1Vascular Endothelial Growth Factor A

Identifiers

PMID22628435
PMCPMC4183139
OpenAlexW2150937878

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.